Skip to content

Clinical trials

Pathologic Complete Response trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Complete Response Status: Unknown status Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20181
20191
20204
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sixth Affiliated Hospital, Sun Yat-sen University2
Changchun Intellicrown Pharmaceutical Co. LTD1
Chinese Academy of Medical Sciences1
Guangdong Provincial People's Hospital1
Jianhua Fu1
Peking University1
Shanghai Pulmonary Hospital, Shanghai, China1
The First Affiliated Hospital with Nanjing Medical University1
Xuejie Jiang1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Complete Response10
Breast Neoplasms4
Rectal Neoplasms2
Carcinoma, Non-Small-Cell Lung1
Esophageal Squamous Cell Carcinoma1
Leukemia, Myeloid1
Leukemia, Myeloid, Acute1
Triple Negative Breast Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.